NewEdge Advisors’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $79.4K | Sell |
1,212
-951
| -44% | -$62.3K | ﹤0.01% | 2502 |
|
|
2025
Q1 | $153K | Sell |
2,163
-23
| -1% | -$1.62K | ﹤0.01% | 2178 |
|
|
2024
Q4 | $144K | Sell |
2,186
-831
| -28% | -$54.6K | ﹤0.01% | 2175 |
|
|
2024
Q3 | $213K | Sell |
3,017
-816
| -21% | -$57.6K | ﹤0.01% | 1980 |
|
|
2024
Q2 | $254K | Sell |
3,833
-324
| -8% | -$21.5K | ﹤0.01% | 1802 |
|
|
2024
Q1 | $282K | Sell |
4,157
-187
| -4% | -$12.7K | ﹤0.01% | 1675 |
|
|
2023
Q4 | $268K | Buy |
4,344
+3,387
| +354% | +$209K | ﹤0.01% | 1592 |
|
|
2023
Q3 | $56.5K | Sell |
957
-300
| -24% | -$17.7K | ﹤0.01% | 2059 |
|
|
2023
Q2 | $75K | Hold |
1,257
| – | – | ﹤0.01% | 1951 |
|
|
2023
Q1 | $73.4K | Sell |
1,257
-90
| -7% | -$5.26K | ﹤0.01% | 1856 |
|
|
2022
Q4 | $84 | Buy |
+1,347
| New | +$84 | ﹤0.01% | 3395 |
|
|
2018
Q4 | – | Sell |
-5,520
| Closed | -$309K | – | 669 |
|
|
2018
Q3 | $309K | Sell |
5,520
-441
| -7% | -$24.7K | 0.02% | 486 |
|
|
2018
Q2 | $300 | Buy |
+5,961
| New | +$300 | 0.03% | 412 |
|